Melanin affinity: a possible explanation of isoxsuprine retention in the horse.
Authors: Törneke K, Larsson C I, Appelgren L E
Journal: Equine veterinary journal
Summary
# Editorial Summary: Melanin affinity and isoxsuprine retention in horses Isoxsuprine's prolonged urinary detectability following cessation of treatment—persisting for up to six weeks post-administration—has long puzzled equine clinicians, particularly given its therapeutic window for performance purposes. Using radiolabelled isoxsuprine and whole-body autoradiography in mice, Törneke and colleagues identified melanin as the primary site of drug retention within the body, with in vitro binding studies revealing significant affinity to both melanin (Kd 0.02 mmol/l) and keratin (Kd 1 mmol/l). When applied directly to pigmented equine skin, the labelled drug demonstrated measurable binding through microautoradiography, confirming that melanin sequestration occurs physiologically in horses. This melanin-binding mechanism provides a plausible explanation for why low-level isoxsuprine metabolites continue appearing in urine weeks after treatment ends, a finding with important implications for competition regulations and washout protocols. For practitioners, this research underscores that prolonged urinary detection does not necessarily indicate recent administration or non-compliance; rather, it reflects genuine pharmacokinetic retention in pigmented tissues—a consideration particularly relevant for darkly pigmented horses and those subject to doping control testing.
Read the full abstract on PubMed
Practical Takeaways
- •Isoxsuprine should not be administered to horses close to competition or drug testing windows due to prolonged tissue retention and urinary detection lasting 6+ weeks
- •The high affinity of isoxsuprine for melanin means horses with pigmented skin may retain the drug longer than those with unpigmented areas
- •When using isoxsuprine therapeutically, clinicians should counsel owners about extended clearance times and document administration dates for regulatory compliance
Key Findings
- •Isoxsuprine is retained in melanin-containing tissues, identified as the primary site of drug accumulation in whole body autoradiography studies
- •In vitro binding studies demonstrated isoxsuprine affinity to melanin with Kd of 0.02 mmol/l and Bmax of 0.2 micromol/mg, and a lower affinity site with similar parameters to keratin
- •Isoxsuprine showed measurable affinity to pigmented horse skin in vitro and on microautoradiography
- •Melanin and keratin binding likely explains the detection of isoxsuprine in horse urine for up to 6 weeks after drug cessation